The latest research from Fore Pharma, Germany Multiple Myeloma Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Multiple Myeloma pipeline products, Multiple Myeloma epidemiology, Multiple Myeloma market valuations and forecast, Multiple Myeloma products sales and competitive landscape in Germany.
The research is classified into nine sections – Multiple Myeloma overview including etiology, pathophysiology, and diagnosis, Multiple Myeloma treatment options, Multiple Myeloma pipeline products, Multiple Myeloma market analysis comprising of Multiple Myeloma epidemiology, key products marketed for Multiple Myeloma, market valuations and forecast, products sales and market shares.
Research Scope: - Multiple Myeloma Pipeline: Find out the products in clinical trials for the treatment of Multiple Myeloma by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products - Multiple Myeloma Epidemiology: Find out the number of patients diagnosed (prevalence) with Multiple Myeloma in Germany - Multiple Myeloma Products: Identify key products marketed and prescribed for Multiple Myeloma in Germany, including trade name, molecule name, and company - Multiple Myeloma Product Sales: Find out the sales revenues of Multiple Myeloma products, both branded and generics, in Germany - Multiple Myeloma Market Valuations: Find out the market size for Multiple Myeloma products in 2015 in Germany. Find out how the market advanced from 2010 and forecast to 2020 - Multiple Myeloma Products Market Share: Find out the market shares for key Multiple Myeloma products in Germany
Benefits of this Research: The research helps executives to - Support monitoring and reporting national Multiple Myeloma market analysis and sales trends - Track competitor drugs sales and market share in Germany Multiple Myeloma market - Track competitive developments in Multiple Myeloma market and present key issues and learnings - Synthesize insights for Multiple Myeloma market and products to drive business performance - Answer key business questions about the Multiple Myeloma market - Evaluate commercial market opportunity assessment, positioning, and segmentation for Multiple Myeloma products - Supports decision making in R&D to long term marketing strategies
Our reports have been used by over 10K customers, including:
138 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Kaposi Sarcoma Market to Reach $146.5 Million by 2027
- Amid the COVID-19 crisis, the global market for Kaposi Sarcoma estimated at US$125.4 Million in the year 2020, is projected to reach a revised size of US$146.5 Million by 2027, growing at a CAGR of 2.2% over the analysis period 2020-2027. HAART,...
216 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Multiple Myeloma Therapeutics Market to Reach $27.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Multiple Myeloma Therapeutics estimated at US$9.9 Billion in the year 2020, is projected to reach a revised size of US$27.1 Billion by 2027, growing at a CAGR of 15.5% over the analysis...
Melanoma - Epidemiology Forecast to 2029
Summary
Melanoma is a malignant neoplasm of melanocytes, the pigment cells in the skin located on the epidermis, the most superficial layer of the skin (World Health Organization, 2017).Melanocytes are embryological derivatives of neural crest tissue, and...
“Basal cell carcinoma - Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Basal cell carcinoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...
573 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Looking Beyond Today’s Challenges to Tomorrow’s Healthcare Needs. Genetic Testing to Reach $18.9 Billion as the Burden of Non-Communicable Diseases Grows Bigger
- The global market for Genetic Testing is forecast to reach US$18.9 billion by the year 2027, trailing a post COVID-19 CAGR of 8.6% over the...
388 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Uterine Cancer Therapeutics and Diagnostics Market to Reach $27.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for Uterine Cancer Therapeutics and Diagnostics estimated at US$19.5 Billion in the year 2020, is projected to reach a revised size of US$27.7 Billion by 2027, growing...
278 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Basal Cell Carcinoma Treatment Market to Reach $9.5 Billion by 2027
- Amid the COVID-19 crisis, the global market for Basal Cell Carcinoma Treatment estimated at US$5.6 Billion in the year 2020, is projected to reach a revised size of US$9.5 Billion by 2027, growing at a CAGR of 7.9% over the analysis...
372 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Cervical Cancer Treatment Market to Reach $9.8 Billion by 2027
- Amid the COVID-19 crisis, the global market for Cervical Cancer Treatment estimated at US$7 Billion in the year 2020, is projected to reach a revised size of US$9.8 Billion by 2027, growing at a CAGR of 4.8% over the analysis period...
198 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Doxorubicin Market to Reach $1.4 Billion by 2027
- Amid the COVID-19 crisis, the global market for Doxorubicin estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at a CAGR of 5.2% over the analysis period 2020-2027. Breast Cancer,...
175 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Myelodysplastic Syndrome (MDS) Drugs Market to Reach $3.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Myelodysplastic Syndrome (MDS) Drugs estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 8.4%...
Cancer
World
China
Europe
United States
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.